Question 1

What is the catalog number for 2- (2-Fluorophenyl) oxirane?

Accepted Answer

The catalog number for 2- (2-Fluorophenyl) oxirane is ZCA24917.

Question 2

What sizes are available for 2- (2-Fluorophenyl) oxirane?

Accepted Answer

2- (2-Fluorophenyl) oxirane is available in the following size(s): 250 mg, 2.5 g.

Question 3

How many pack sizes does 2- (2-Fluorophenyl) oxirane come in?

Accepted Answer

2- (2-Fluorophenyl) oxirane is available in 2 different pack sizes.

Question 4

Is 2- (2-Fluorophenyl) oxirane in stock?

Accepted Answer

2- (2-Fluorophenyl) oxirane is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 6

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 7

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

2- (2-Fluorophenyl) oxirane

Product Specifications

CAS Number

MDL Number

Smiles

Molecular Formula

Molecular Weight

Controlled

Available Sizes

Frequently Asked Questions

Explore Other Products

4-O-Benzyl-3-hydroxy Tyrosol Alpha-Acetate-3-Sulfate Sodium Salt

Recombinant APPL Antibody

Recombinant APPL Antibody

Recombinant APPL Antibody

TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF740 conjugate, 0.1mg/mL

C13orf30 (FAM216B) (NM_182508) Human Recombinant Protein